Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients.
New discovery offers hope for overcoming CAR-T cell therapy resistance
- Post author:
- Post published:
- Post category:uncategorized